AU5331796A - Vectors for the transfection of eucaryotic cells, their use and target cells transfected thereby - Google Patents

Vectors for the transfection of eucaryotic cells, their use and target cells transfected thereby

Info

Publication number
AU5331796A
AU5331796A AU53317/96A AU5331796A AU5331796A AU 5331796 A AU5331796 A AU 5331796A AU 53317/96 A AU53317/96 A AU 53317/96A AU 5331796 A AU5331796 A AU 5331796A AU 5331796 A AU5331796 A AU 5331796A
Authority
AU
Australia
Prior art keywords
transfection
vectors
eucaryotic
target cells
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU53317/96A
Inventor
Peter Kulmburg
Albrecht Lindemann
Roland Mertelsmann
Felicia Rosenthal
Hendrik Veelken
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universitaetsklinikum Freiburg
Original Assignee
Universitaetsklinikum Freiburg
Albert Ludwigs Universitaet Freiburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitaetsklinikum Freiburg, Albert Ludwigs Universitaet Freiburg filed Critical Universitaetsklinikum Freiburg
Publication of AU5331796A publication Critical patent/AU5331796A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES
AU53317/96A 1995-04-18 1996-04-17 Vectors for the transfection of eucaryotic cells, their use and target cells transfected thereby Abandoned AU5331796A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE1995114310 DE19514310A1 (en) 1995-04-18 1995-04-18 Vectors for the transfection of eukaryotic cells, their use and thus transfected target cells
DE19514310 1995-04-18
PCT/DE1996/000697 WO1996033272A1 (en) 1995-04-18 1996-04-17 Vectors for the transfection of eucaryotic cells, their use and target cells transfected thereby

Publications (1)

Publication Number Publication Date
AU5331796A true AU5331796A (en) 1996-11-07

Family

ID=7759829

Family Applications (1)

Application Number Title Priority Date Filing Date
AU53317/96A Abandoned AU5331796A (en) 1995-04-18 1996-04-17 Vectors for the transfection of eucaryotic cells, their use and target cells transfected thereby

Country Status (3)

Country Link
AU (1) AU5331796A (en)
DE (1) DE19514310A1 (en)
WO (1) WO1996033272A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19542051C2 (en) * 1995-11-10 2000-03-23 Asta Medica Ag Genetically modified tumorigenic cell lines and their use for testing anti-tumor agents
DE19707493C1 (en) * 1997-02-25 1998-02-26 Univ Ludwigs Albert Nucleic acid construct for trans-gene expression
FI972293A (en) 1997-05-30 1998-12-01 Joseph Atabekov Methods for co-expression of more than one gene
US6933378B2 (en) 1997-05-30 2005-08-23 Joseph Atabekov Methods for coexpression of more than one gene in eukaryotic cells
CA2309344A1 (en) * 1997-11-12 1999-05-20 Valentis, Inc. Expression plasmids for multiepitope nucleic acid-based vaccines
AU767880B2 (en) * 1998-03-16 2003-11-27 Introgen Therapeutics, Inc. Multigene vectors
US6610508B1 (en) * 1999-03-08 2003-08-26 Anadys Pharmaceuticals, Inc. Translation driver system and methods for use thereof
IL148785A0 (en) 1999-10-13 2002-09-12 Immunex Corp Vectors and methods for recombinant protein expression
EP1685247B1 (en) * 2003-10-03 2009-11-11 Promega Corporation Vectors for directional cloning
US8293503B2 (en) 2003-10-03 2012-10-23 Promega Corporation Vectors for directional cloning
WO2011113841A1 (en) * 2010-03-16 2011-09-22 Robert Steinfeld Eukaryotic vector

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4036389A (en) * 1988-07-29 1990-03-05 Zymogenetics Inc. High efficiency translation of polycistronic messages in eucaryotic cells
DE69232438T2 (en) * 1991-08-07 2002-10-10 W French Anderson INTERNAL RIBOSOM INPUTS INCLUDING RETROVIRAL VECTORS
IL102404A0 (en) * 1992-07-03 1993-01-14 Daniel Zurr Method and means for the production of gene products
DE4228457A1 (en) * 1992-08-27 1994-04-28 Beiersdorf Ag Production of heterodimeric PDGF-AB using a bicistronic vector system in mammalian cells
DE4228458A1 (en) * 1992-08-27 1994-06-01 Beiersdorf Ag Multicistronic expression units and their use
EP0706319A4 (en) * 1993-01-20 1998-04-22 Biotransplant Inc Retroviral vectors capable of expressing multimeric proteins from multiple translational initiation sites
JP4375759B2 (en) * 1993-04-21 2009-12-02 ザ・ユニバーシティ・コート・オブ・ザ・ユニバーシティ・オブ・エディンバラ Expression of heterologous genes according to targeted expression characteristics
DE4325699A1 (en) * 1993-07-30 1995-02-02 Hartmut Berns Recombinant DNA construct
FR2722208B1 (en) * 1994-07-05 1996-10-04 Inst Nat Sante Rech Med NEW INTERNAL RIBOSOME ENTRY SITE, VECTOR CONTAINING SAME AND THERAPEUTIC USE
AT403167B (en) * 1994-11-14 1997-11-25 Immuno Ag SELECTION AND EXPRESSION OF FOREIGN PROTEINS BY MEANS OF A SELECTION-AMPLIFICATION SYSTEM

Also Published As

Publication number Publication date
DE19514310A1 (en) 1996-10-24
WO1996033272A1 (en) 1996-10-24

Similar Documents

Publication Publication Date Title
AU5425298A (en) Serine substituted mutants of bcl-xl/bcl-2 associated cell death regulator
AU7472496A (en) Chimeric receptor genes and cells transformed therewith
AU7612196A (en) Functional human hematopoietic cells
AU7465194A (en) Transfection process
AU5723696A (en) Gene therapy using replication competent targeted adenoviral vectors
EP0788508A4 (en) Novel system for isolating and identifying eukaryotic cells transfected with genes and vectors
AU4597496A (en) Liposome-mediated transfection of central nervous system cells
AU1024397A (en) Disruption of expression of multiple alleles of mammalian genes
AU699020B2 (en) Liquid formulations of 1,2-benzisothiazolin-3-one
CA2222425A1 (en) Immortalization and disimmortalization of cells
AU7979098A (en) Complete activation of mammalian oocytes
AU1684097A (en) Beta-secretase isolated from human 293 cells
AU5331796A (en) Vectors for the transfection of eucaryotic cells, their use and target cells transfected thereby
AU673650B2 (en) Novel vectors and use thereof for capturing target genes
EP0801331A3 (en) Electrophotosensitive material
AUPN816196A0 (en) Regulation of eukaryotic gene expression
EP0738934A3 (en) Electrophotosensitive material
AU5315796A (en) Mammalian expression vectors
AU7444191A (en) Mammalian expression vectors
AU7217194A (en) Transformed mammalian cells capable of expressing cecropin b
AU1751392A (en) Mammalian expression vector
AU2285200A (en) Non-viral transfection vector
AU7136196A (en) Pharmaceutical composition which is useful for the transfection of nucleic acids, and uses thereof
AU2682895A (en) EG Cells of Ungulates
AU2408397A (en) Ob protein receptor genes and use of the same